ForCast Orthopedics was founded in 2017 by an experienced med-tech entrepreneur and a leading orthopedic surgeon. We are dedicated to the development of devices for targeted drug delivery to improve patient outcomes. Our lead indication automates a research method that has been clinically demonstrated to achieve superior patient outcomes compared with the standard of care for orthopedic, Periprosthetic Joint Infections (PJI). We believe our drug delivery implant will become the new gold standard in treatment replacing inadequate current methods, which suffer from low success rates, high cost and high patient morbidity including the risk of amputation.